Switch theme
Sign up to access all valuation multiples
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
2015
3K+
LTM Revenue $1.1B
LTM EBITDA $559M
$5.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sotera Health has a last 12-month revenue (LTM) of $1.1B and a last 12-month EBITDA of $559M.
In the most recent fiscal year, Sotera Health achieved revenue of $1.1B and an EBITDA of $442M.
Sotera Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sotera Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| Gross Profit | $660M | XXX | $602M | XXX | XXX | XXX |
| Gross Margin | 59% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $559M | XXX | $442M | XXX | XXX | XXX |
| EBITDA Margin | 50% | XXX | 40% | XXX | XXX | XXX |
| EBIT | $448M | XXX | $298M | XXX | XXX | XXX |
| EBIT Margin | 40% | XXX | 27% | XXX | XXX | XXX |
| Net Profit | $205M | XXX | $44.4M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Sotera Health's stock price is $12.
Sotera Health has current market cap of $3.5B, and EV of $5.5B.
See Sotera Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.5B | $3.5B | XXX | XXX | XXX | XXX | $0.72 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Sotera Health has market cap of $3.5B and EV of $5.5B.
Sotera Health's trades at 5.0x EV/Revenue multiple, and 12.5x EV/EBITDA.
Equity research analysts estimate Sotera Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sotera Health has a P/E ratio of 16.9x.
See valuation multiples for Sotera Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.5B | XXX | $3.5B | XXX | XXX | XXX |
| EV (current) | $5.5B | XXX | $5.5B | XXX | XXX | XXX |
| EV/Revenue | 4.9x | XXX | 5.0x | XXX | XXX | XXX |
| EV/EBITDA | 9.9x | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | 12.3x | XXX | 18.5x | XXX | XXX | XXX |
| EV/Gross Profit | 8.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 16.9x | XXX | 78.3x | XXX | XXX | XXX |
| EV/FCF | 26.2x | XXX | 122.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSotera Health's last 12 month revenue growth is 5%
Sotera Health's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Sotera Health's rule of 40 is 43% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sotera Health's rule of X is 62% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Sotera Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 50% | XXX | 40% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | 43% | XXX | 45% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 62% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sotera Health acquired XXX companies to date.
Last acquisition by Sotera Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Sotera Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Sotera Health founded? | Sotera Health was founded in 2015. |
| Where is Sotera Health headquartered? | Sotera Health is headquartered in United States of America. |
| How many employees does Sotera Health have? | As of today, Sotera Health has 3K+ employees. |
| Who is the CEO of Sotera Health? | Sotera Health's CEO is Mr. Michael B. Petras, Jr. |
| Is Sotera Health publicy listed? | Yes, Sotera Health is a public company listed on NAS. |
| What is the stock symbol of Sotera Health? | Sotera Health trades under SHC ticker. |
| When did Sotera Health go public? | Sotera Health went public in 2020. |
| Who are competitors of Sotera Health? | Similar companies to Sotera Health include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Sotera Health? | Sotera Health's current market cap is $3.5B |
| What is the current revenue of Sotera Health? | Sotera Health's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Sotera Health? | Sotera Health revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Sotera Health? | Current revenue multiple of Sotera Health is 4.9x. |
| Is Sotera Health profitable? | Yes, Sotera Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sotera Health? | Sotera Health's last 12 months EBITDA is $559M. |
| What is Sotera Health's EBITDA margin? | Sotera Health's last 12 months EBITDA margin is 50%. |
| What is the current EV/EBITDA multiple of Sotera Health? | Current EBITDA multiple of Sotera Health is 9.9x. |
| What is the current FCF of Sotera Health? | Sotera Health's last 12 months FCF is $210M. |
| What is Sotera Health's FCF margin? | Sotera Health's last 12 months FCF margin is 19%. |
| What is the current EV/FCF multiple of Sotera Health? | Current FCF multiple of Sotera Health is 26.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
